PROT < sub > 3 < /sub > EcT, engineered Escherichia coli for the targeted delivery of therapeutics
Trends Mol Med. 2023 Aug 11:S1471-4914(23)00157-0. doi: 10.1016/j.molmed.2023.07.007. Online ahead of print.NO ABSTRACTPMID:37574350 | DOI:10.1016/j.molmed.2023.07.007
Source: Trends in Molecular Medicine - Category: Molecular Biology Authors: Coral Gonz ález-Prieto Jason P Lynch Cammie F Lesser Source Type: research
More News: Gastroenteritis | Molecular Biology